Winning the Long War Against AIDS

Here’s the story of one Canadian doctor who has spent decades helping the medical world turn the tide on the HIV/AIDS pandemic.

In 1981, AIDS was first recognized as a new disease. Caused by the HIV virus, it first presented as a strange kind of pneumonia. Doctors soon realized that although the pneumonia was treatable, the destruction of the immune systems of AIDS patients meant that new complications were always waiting. Treating the symptoms alone only extended lives by weeks or months. The world watched as AIDS grew to a global pandemic.

Soon, researchers turned to treating the virus itself, instead of just the symptoms it caused. Controlling the HIV virus not only brought AIDS symptoms under control, but also drastically reduced its transmission. This new paradigm of treatment as prevention has reduced the global AIDS pandemic to a rare occurrence, and revolutionized the way we approach infectious diseases.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below